News & Events

March 2014

Share
masthead_enewsletter_CDINotebook

MARCH 2014

Welcome to our monthly enewsletter, CDI Notebook, focused on keeping you abreast of the latest innovations using CDI’s iCell® and MyCell® products.

In this issue:
Videos
Conference News
Application Notes & Protocols
Press

enewsletter_hr-big

Videos

video

Dr. Roberto Iacone, Roche, Discusses the Use of iPS Cell-derived Cardiomyocytes in Diabetic Cardiomyopathy Research. Hear why Dr. Iacone employs iCell and MyCell Cardiomyocytes in Roche’s research of cardiomyopathy associated with Type II diabetes and how these cells could lead to individualized therapeutics.

Video>>

enewsletter_hr-big

Conference News

Society of Toxicology and ToxExpo (Mar 23 – 27 | Phoenix, AZ | Booth 518). Join us at our customer reception, the 19 posters featuring iCell technology, and the numerous presentations showcasing the utility of stem cells in toxicity screens including:

reception

  • Stem Cells in Toxicology (Mar 23 | 1:15 –
    5:00 pm)
  • Induced Human Pluripotent Stem Cells and Their Differentiated Progeny Cells: Implementation in Toxicity Testing
    (Mar 24 | 9:15 am – 12:00 pm)
  • Use of Stem Cells in Toxicity Testing—From Basic Research to Personalized Toxicology (Mar 24 | 2:00 – 4:45 pm)
  • Phenotypic In Vitro Assessment of Compound Effects on Cardiomyocyte Physiology Using Human iPSC-derived Cardiomyocytes (Mar 25 | 1:30 – 2:30 pm)
  • Beyond hERG: Novel Cardiovascular
    De-risking Strategies and Their Regulatory Acceptance
    (Mar 26 | 1:30 – 4:15 pm)

enewsletter_hr-big

Application Notes & Protocols

application2

Measuring Cardiac Electrical Activity: Field Potential Detection with Axion Maestro Multielectrode Array. Details handling iCell Cardiomyocytes for use on an Axion Maestro Multielectrode Array system, providing basic instructions for compound treatments, data acquisition, and analysis.

Protocol>>

enewsletter_hr-big

Press

Reluctant Star of Stem Cell Research (Financial Times). Learn about the quest to control a cell’s developmental clock and other current research projects of Dr. James Thomson, CDI founder and stem cell innovator.

Article>>

Cellular Dynamics, Seizing the Present, Turns Stem Cells into Cash (Xconomy). Find out why CDI’s strategy of “stem cells-as-a-lab-tool-you’ve-gotta-have” is catching on.

Article>>

(Pluri)potent Acid (SciBX). Read industry and academic perspectives on the recently published STAP-cell generating methodology (Nature, Jan 2014), and why CDI and others are trying to replicate this potentially pioneering process.

Article>>

enewsletter_hr-big

© 2014 Cellular Dynamics International, Inc.
525 Science Drive, Madison, WI 53711
+1 (608) 310-5100 or toll-free (877) 310-6688
www.cellulardynamics.com
Follow us: facebook16x16px_green linkedin16x16px_green twitter16x16px_green youtube16x16px_green